Shanghai InnoStar Bio-tech Co., Ltd.

¥86.00As of Sun 8 Nov 2026, 12:00 UTC
SSE:688710Healthcare
Country China
PE (Fwd) •••
TSR 2Y CAGR 60.72%
Div yield —
ROE 3.06%
Drug Manufacturers (General)
Beta (5Y) (0.16)
PE TTM 146.1
TSR TTM 81.51%
Mkt cap ¥12.12B
ROIC 4.72%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥105
22.37%
5.66%
Hold 11|0|9|10|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.85
1.92
2.01
2.22
(0.76%)
6.50%
6.68%
19.07%
Revenue¥B
1.389
1.423
1.448
1.496
5.33%
3.76%
8.14%
10.01%
Peers (US$1.806B)
Cap (US$)
PE
1.769B
27.62x
1.545B
—
1.879B
20.53x
Capital
TTM
5Y
10Y
Leveragex
0.049
0.395
0.358
EBIT/Intx
1.132
0.217
0.211
Own earn%
(12.43)
(110.83)
(101.33)
Sh yield%
30.89
31.32
30.12
Owners
Insiders/Inst%
1.00
55.29
Short interest%
2.03
SBC / revenue%
4.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
22–25
$1 testx
0.0
Incr. ROIC%
6